Report an error

Spotted something inaccurate in “Amycretin Dual-Receptor Agonist Achieves 24.3% Weight Loss in Trials”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.